NCT05146219 2024-12-30
Study of TY-9591 in Patients With a Lung Cancer With Brain or Leptomeningeal Metastases With EGFR Mutation
TYK Medicines, Inc
Phase 2 Completed
Clinical Trials
3 trialsNCT02228369 2021-01-05
BLOOM
AstraZeneca
Phase 1 Completed
NCT00854867 2014-02-24
Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Mundipharma Research Limited
Phase 1 Completed